Evidence map›Paper›PMID 35982419›Full record

ArticleBMC infectious diseases2022

Clinical testing on SARS-CoV-2 swab samples using reverse-transcription loop-mediated isothermal amplification (RT-LAMP).

Meng Yee Lai, Fatma Diyana Mohd Bukhari, Nur Zulaikha Zulkefli, Ilyiana Ismail, Nur Izati Mustapa, Tuan Suhaila Tuan Soh, Afifah Haji Hassan, Kalaiarasu M Peariasamy, Yee Leng Lee, Jeyanthi Suppiah and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Enhanced Specificity in Colorimetric LAMP Assay forJournal of fungi (Basel, Switzerland) · 2024
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Meng Yee LaiDepartment of Parasitology, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Fatma Diyana Mohd BukhariDepartment of Parasitology, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Nur Zulaikha ZulkefliDepartment of Parasitology, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Ilyiana IsmailDepartment of Pathology, Hospital Sungai Buloh, Ministry of Health, Kuala Lumpur, Malaysia.
Nur Izati MustapaDepartment of Pathology, Hospital Sungai Buloh, Ministry of Health, Kuala Lumpur, Malaysia.
Tuan Suhaila Tuan SohDepartment of Pathology, Hospital Sungai Buloh, Ministry of Health, Kuala Lumpur, Malaysia.
Afifah Haji HassanDepartment of Pathology, Hospital Sungai Buloh, Ministry of Health, Kuala Lumpur, Malaysia.
Kalaiarasu M PeariasamyInstitute for Clinical Research, National Institutes of Health, Ministry of Health, Kuala Lumpur, Malaysia.
Yee Leng LeeClinical Research Centre, Hospital Sungai Buloh, Ministry of Health, Kuala Lumpur, Malaysia.
Jeyanthi SuppiahVirology Unit, Infectious Disease Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health, Kuala Lumpur, Malaysia.
Ravindran ThayanVirology Unit, Infectious Disease Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health, Kuala Lumpur, Malaysia.
Mohd Khairi Mat IsaSelia-Tek Holdings Sdn Bhd, Lot 18, Jalan Teknologi 3/5, Taman Sains Selangor, 47810, Kota Damansara, Selangor, Malaysia.
Nur Zafirah Abdul WahidSelia-Tek Holdings Sdn Bhd, Lot 18, Jalan Teknologi 3/5, Taman Sains Selangor, 47810, Kota Damansara, Selangor, Malaysia.
Yee Ling LauDepartment of Parasitology, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia. lauyeeling@um.edu.my.
Ministry of Health · MYUniversity of Malaya · MYTechnology Holding (United States) · USHospital Sungai Buloh · MYInstitute for Medical Research · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh cost of commercial RNA extraction kits limits the testing efficiency of SARS-CoV-2. Here, we developed a simple nucleic acid extraction method for the detection of SARS-CoV-2 directly from nasopharyngeal swab samples.

methodsA pH sensitive dye was used as the end point detection method. The obvious colour changes between positive and negative reactions eliminates the need of other equipment.

resultsClinical testing using 260 samples showed 92.7% sensitivity (95% CI 87.3-96.3%) and 93.6% specificity (95% CI 87.3-97.4%) of RT-LAMP.

conclusionsThe simple RNA extraction method minimizes the need for any extensive laboratory set-up. We suggest combining this simple nucleic acid extraction method and RT-LAMP technology as the point-of care diagnostic tool.

Indexed as

COVID-19COVID-19 TestingMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesSARS-CoV-2HumansNasopharynxPoint-of-Care SystemsRNA, ViralSensitivity and SpecificityRNA, ViralDiagnosisPhenol redpH sensitive indicatorRT-LAMPSARS-CoV-2

Identifiers

PMID35982419
PMCPMC9387413
OpenAlexW4292682989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.